Literature DB >> 23620416

Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.

Jung-Yen Liu1, Shih-Min Wang, I-Chun Chen, Chun-Keung Yu, Ching-Chuan Liu.   

Abstract

Coxsackievirus B (CVB) and enterovirus 71 (EV71) are important causes of severe enteroviral diseases in neonates or young children in Taiwan. CVB can cause fulminant hepatitis, myocarditis or meningoencephalitis. This study was designed to explore the role of coxsackievirus-adenovirus receptor (CAR) in the pathogenesis of CVB3-infected hepatocytes via in vitro and mice studies. CVB3 (CVB3/2630) was isolated from liver tissue of a neonate with fulminant hepatitis. Cell lines A549, HeLa, HEp2 and Huh-7 were maintained in Dulbecco's modified Eagle's medium. Mice progeny 1 or 7 days old were used in the experiments. Viremia was noted in 7-day-old ICR mice 2 h after intraperitoneal injection. The highest viral titers were detected in blood, liver and spleen. Histopathological studies of the liver demonstrated polymorphonuclear cell infiltration, massive hepatic cell necrosis and apoptosis. CAR was expressed more in liver than in other tissues. Expression of CAR decreased with mouse age. Anti-CAR monoclonal antibody prevented infection of Huh-7 cells from CVB3. Furthermore, anti-CAR monoclonal antibody pretreatment can reduce mortality and decrease the level of liver enzymes in CVB3-infected mice. These findings indicate that CAR plays an important role in the initiation of CVB infections and is closely associated with hepatotropism and age-specific susceptibility.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620416     DOI: 10.1111/2049-632X.12044

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  10 in total

1.  Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Authors:  Rakesh H Basavalingappa; Rajkumar Arumugam; Ninaad Lasrado; Bharathi Yalaka; Chandirasegaran Massilamany; Arunakumar Gangaplara; Jean-Jack Riethoven; Shi-Hua Xiang; David Steffen; Jay Reddy
Journal:  Mol Immunol       Date:  2020-06-29       Impact factor: 4.407

2.  Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Authors:  K Lind; E Svedin; R Utorova; V M Stone; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

3.  Expression Profile and Function Analysis of Long Non-coding RNAs in the Infection of Coxsackievirus B3.

Authors:  Lei Tong; Ye Qiu; Hui Wang; Yunyue Qu; Yuanbo Zhao; Lexun Lin; Yan Wang; Weizhen Xu; Wenran Zhao; Hongyan He; Guangze Zhao; Mary H Zhang; Decheng Yang; Xingyi Ge; Zhaohua Zhong
Journal:  Virol Sin       Date:  2019-08-06       Impact factor: 4.327

Review 4.  Coxsackievirus B3-Its Potential as an Oncolytic Virus.

Authors:  Anja Geisler; Ahmet Hazini; Lisanne Heimann; Jens Kurreck; Henry Fechner
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

5.  Identification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis.

Authors:  Xiuzhen Li; Yanhua Xia; Shengping Huang; Fadi Liu; Ying Ying; Qiufang Xu; Xin Liu; Guili Jin; Christopher J Papasian; Jack Chen; Mingui Fu; Xiaotian Huang
Journal:  Sci Rep       Date:  2015-08-28       Impact factor: 4.379

6.  Transcriptome analysis reveals dynamic changes in coxsackievirus A16 infected HEK 293T cells.

Authors:  Jun Jin; Rujiao Li; Chunlai Jiang; Ruosi Zhang; Xiaomeng Ge; Fang Liang; Xin Sheng; Wenwen Dai; Meili Chen; Jiayan Wu; Jingfa Xiao; Weiheng Su
Journal:  BMC Genomics       Date:  2017-01-25       Impact factor: 3.969

7.  Hepatocytes trap and silence coxsackieviruses, protecting against systemic disease in mice.

Authors:  Taishi Kimura; Claudia T Flynn; J Lindsay Whitton
Journal:  Commun Biol       Date:  2020-10-16

8.  Adenovirus-Mediated FasL Minigene Transfer Endows Transduced Cells with Killer Potential.

Authors:  Madalina Dumitrescu; Violeta Georgeta Trusca; Lorand Savu; Ioana Georgeta Stancu; Attila Cristian Ratiu; Maya Simionescu; Anca Violeta Gafencu
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

9.  Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.

Authors:  Wolfgang Koestner; Julia Spanier; Tanja Klause; Pia-K Tegtmeyer; Jennifer Becker; Vanessa Herder; Katharina Borst; Daniel Todt; Stefan Lienenklaus; Ingo Gerhauser; Claudia N Detje; Robert Geffers; Martijn A Langereis; Florian W R Vondran; Qinggong Yuan; Frank J M van Kuppeveld; Michael Ott; Peter Staeheli; Eike Steinmann; Wolfgang Baumgärtner; Frank Wacker; Ulrich Kalinke
Journal:  PLoS Pathog       Date:  2018-08-03       Impact factor: 6.823

Review 10.  Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus.

Authors:  Cinzia Auriti; Domenico Umberto De Rose; Alessandra Santisi; Ludovica Martini; Fiammetta Piersigilli; Iliana Bersani; Maria Paola Ronchetti; Leonardo Caforio
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-06-10       Impact factor: 6.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.